Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  1992-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.55.3.181PMID 1564476PMCID PMC1014720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients.

  1991cited by this paper
• Diffuse lewy body disease in Japan

  1990cited by this paper
• Striatonigral degeneration. A clinicopathological study.

  1990cited by this paper
• Clinically atypical expression of pathologically typical Lewy-body parkinsonism.

  1990cited by this paper
• New developments in the pathology of Parkinson's disease.

  1990cited by this paper
• NEURONAL LOSS IN THE SUBSTANTIA NIGRA IN PATIENTS WITH ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE IN RELATION TO EXTRAPYRAMIDAL SYMPTOMS AND DEMENTIA

  1989cited by this paper
• Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors?

  1989cited by this paper
• Extrapyramidal signs in dementia of Alzheimer type.

  1989cited by this paper
• Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex.

  1989cited by this paper
• Diagnosis of Alzheimer's disease.

  1988cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases

  1988cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper
• The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brainstem.

  1974cited by this paper
• The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brainstem.

  1974cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper
• Progressive supranuclear palsy.

  1972cited by this paper
• AN ESSAY ON THE SHAKING PALSY

  1969cited by this paper
• Parkinsonism

  1967cited by this paper
• Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia

  1964cited by this paper

• Is Parkinson’s disease getting older? Demographic and modifiable determinants of age at onset in a large Italian tertiary care cohort

  2026cites this paper
• THE IMPACT OF POLYPHARMACY ON FALL RISK IN PATIENTS WITH PARKINSON’S DISEASE

  2026cites this paper
• White Matter Alterations in Right-Onset Versus Left-Onset Parkinson's Disease in an Early Stage.

  2026cites this paper
• Parkinsonism in Idiopathic Normal Pressure Hydrocephalus or Hydrocephalic Presentation in Parkinson's disease: A Report of Three Cases.

  2026cites this paper
• Identifying Drugs Associated With Parkinson's Disease Risk Using Machine Learning

  2026cites this paper
• Current Neuroimaging Modalities to Distinguish Parkinson's Disease from its Mimics: Imaging Features and Implications for Clinical Practice.

  2026cites this paper
• Modulation of Bromo- and Extra-Terminal Domain (BET) Proteins Exerts Neuroprotective Effects in Cell Culture Models of Parkinson’s Disease

  2026cites this paper
• Advances in cellular and structural engineering of brain organoids for disease modeling: A Comprehensive Review.

  2026cites this paper
• Similar Postural Response Improvements Following a Single Session of Transcranial Direct Current Stimulation in Fallers and Non-Fallers with Parkinson’s Disease: A Pilot Study

  2026cites this paper
• Exploring cardiac autonomic dysfunction in synucleinopathies with parkinsonism through awake–sleep stages: a possible connection to cardiovascular death

  2026cites this paper
• Anxiety is associated with increased risk of suicidality in Parkinson's disease.

  2026cites this paper
• How Did the COVID-19 Pandemic Affect the Non-Motor Symptoms of Patients with Parkinson's Disease?

  2026cites this paper
• Parkinson's Disease Biomarkers: Bridging the Gap Between Diagnosis and Treatment.

  2026cites this paper
• Neuroimaging correlates of cognitive stages in Parkinson's disease: A multimodal MRI study.

  2026cites this paper
• Of the manuscript: relationship between serum Zonulin level and sarcopenia in Parkinson’s disease

  2026cites this paper
• Gothelf's Haplotype of COMT in Parkinson's Disease: A Case-Control Study.

  2026cites this paper
• Automated differentiation of parkinsonian disorders: an ROI-based analysis of subcortical shape and cortical surface features

  2026cites this paper
• Altered cerebrovascular haemodynamics in Parkinson's disease: Insights from 4D flow MRI.

  2026cites this paper
• Responsiveness of the Falls Efficacy Scale-International and Activities-Specific Balance Confidence Scale in Parkinson's disease.

  2026cites this paper
• Effects of deep brain stimulation on non motor fluctuations in Parkinson's disease (assessed with the NMF severity scale).

  2026cites this paper
• Clinical Characteristics of Geriatric Patients With de novo Parkinson’s Disease Compared with the Non-Geriatric Population: Adapting to Changes in the Era of Aging

  2026cites this paper
• Evaluation of the neurotrophic peptide mixture in pathogenetic therapy of patients with Parkinson’s disease

  2026cites this paper
• Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease.

  2026cites this paper
• Effectiveness of Cognitive Enhancement Programs in Parkinson's Disease Patients with Mild Cognitive Impairment: A Narrative Review.

  2026cites this paper
• Dynamic thalamocortical functional connectivity disruptions in Parkinson’s disease with probable REM sleep behavior disorder

  2026cites this paper
• Usability of assistive cutlery for people with Parkinson's disease: a user-centred design prototype.

  2026cites this paper
• Deep learning-based one-stop 11C-CFT and 18F-FDG dual-tracer brain PET imaging protocol for Parkinson's disease.

  2026cites this paper
• Functional Reorganization of Motor Subcircuits in Parkinson’s disease

  2026cites this paper
• Patients with symmetric Parkinson’s disease do poorly with subthalamic stimulation

  2026cites this paper
• Insole-Derived Plantar Pressure Variability Reveals Dual-Task Gait Differences in Early-Stage Parkinson’s Disease

  2026cites this paper
• Parkinson's disease subtypes and their relationship to dementia with Lewy bodies: a comparative neuroimaging analysis based on nigrostriatal degeneration.

  2026cites this paper
• Data-driven clinical decision support tool for diagnosing mild cognitive impairment in Parkinson’s disease

  2026cites this paper
• Elevated cerebral oxygen extraction fraction in Parkinson’s disease correlates with motor impairment severity

  2026cites this paper
• Altered topological properties in PD patients with probable REM sleep behavior disorder through fuctional MRI

  2026cites this paper
• Associations between glymphatic dysfunction, white matter injury, and cognitive decline in Parkinson's disease

  2026cites this paper
• Predicting Phenoconversion in Isolated RBD: Machine Learning and Explainable AI Approach

  2025cites this paper
• Platelet miRNAs as early biomarkers for progression of idiopathic REM sleep behavior disorder to a synucleinopathy

  2025cites this paper
• Lip and Jaw Tremor in Parkinson’s Disease

  2025cites this paper
• The natural history of body-first versus brain-first Parkinson’s disease subtypes

  2025cites this paper
• Subthalamic Deep Brain Stimulation: Mapping Non‐Motor Outcomes to Structural Connections

  2025cites this paper
• Correlation between basal ganglia nuclei and cortical gray matter volume changes in different motor subtypes of Parkinson’s disease

  2025cites this paper
• Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy

  2025cites this paper
• “Dance Well”—A Multisensory Artistic Dance Intervention for People with Parkinson’s Disease: A Pilot Study

  2025cites this paper
• Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence

  2025cites this paper
• Plasma miRNA Biomarker Signatures in Parkinsonian Syndromes

  2025cites this paper
• Pain and Fatigue in Parkinson’s Disease: Exploring Their Interrelation and Mediating Variables

  2025cites this paper
• Influence of WWOX/MAF genes on cognitive performance in patients with Parkinson's disease.

  2025cites this paper
• Reduced automaticity in freezing of gait is associated with elevated cortico-cerebellar connectivity

  2025cites this paper
• Treatment for Dyskinesia in Parkinson's Disease: A Network Meta‐analysis of Randomized Controlled Trials

  2025cites this paper
• Plasma GFAP and NfL associate with cerebral glucose metabolism in putative brain-first and body-first Parkinson’s disease subtypes

  2025cites this paper
• Gradients of Nigrostriatal Iron Deposition in Healthy Aging and Synucleinopathies

  2025cites this paper
• Cortical Activation During Split-Belt Treadmill Walking in People With Parkinson’s Disease and Healthy Controls

  2025cites this paper
• Cyclic Alternating Pattern of EEG Activities and Heart Rate Variability in Parkinson's Disease Patients during Deep Sleep.

  2025cites this paper
• Device-aided therapies (DATs) in Parkinson’s disease (PD). The DATs-PD GETM Spanish Registry Protocol Study

  2025cites this paper
• Factors Correlated with Social Participation of Latin American Older Adults with Mild/Moderate Parkinson’s Disease

  2025cites this paper
• Biallelic Variants in EPG5 Gene Are Associated with Parkinson's Disease

  2025cites this paper
• Effects of essential tremor on longevity and mortality rates in families

  2025cites this paper
• Identification of Common Brain Protein and Genetic Loci Between Parkinson's Disease and Lewy Body Dementia

  2025cites this paper
• Disrupted coordination between primary and high-order cognitive networks in Parkinson’s disease based on morphological and functional analysis

  2025cites this paper
• Skin α-synuclein assays in diagnosing Parkinson’s disease: a systematic review and meta-analysis

  2025cites this paper
• Cholinergic System Changes in Dopa‐Unresponsive Freezing of Gait in Parkinson's Disease

  2025cites this paper
• Head tremor in Parkinson´s Disease, clinical Associations and response to therapy

  2025cites this paper
• Association of Enterococcus faecalis and tyrosine decarboxylase gene levels with levodopa pharmacokinetics in Parkinson’s disease

  2025cites this paper
• Study of autocorrelations and uncertainties applied to patients with Parkinson’s disease

  2025cites this paper
• Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years

  2025cites this paper
• The abnormal audiovisual conflict in Parkinson’s disease patients is manifested in perception rather than response

  2025cites this paper
• Relationship of cognitive decline with glucocerebrosidase activity and amyloid‐beta 42 in DLB and PD

  2025cites this paper
• Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies

  2025cites this paper
• Differentiating patterns of neuro-circuitry abnormalities in tremor dominant parkinson’s disease and multiple system atrophy: a resting-state fMRI study

  2025cites this paper
• Effects of Cognitive Training on Balance and Motor Symptoms in Parkinson's Disease: An Exploratory Randomized Controlled Trial

  2025cites this paper
• Test-retest reliability and construct validity of the King's Parkinson's Disease Pain Scale - Brazilian version.

  2025cites this paper
• Uncovering Potential Biomarkers and Constructing a Prediction Model Associated with Iron Metabolism in Parkinson’s Disease

  2025cites this paper
• Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes

  2025cites this paper
• Dysphagia in Parkinson´s disease. A 5-year follow-up study

  2025cites this paper
• Convergent reductions in interhemispheric functional, structural and callosal connectivity in Parkinson’s disease

  2025cites this paper
• Heartbeat signature for predicting motor and non-motor involvement among nonparkinsonian LRRK2 G2019S mutation carriers

  2025cites this paper
• Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.

  2025cites this paper
• HTT, ATXN1 and ATXN2 CAG triplet repeat sizes: exploring their role in the disease risk and cancer comorbidity in Parkinson’s disease

  2025cites this paper
• How do people with Parkinson’s disease perceive challenges in handling cutlery? – A mixed study

  2025cites this paper
• Parkinsonism in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Clinical Features and Biomarkers

  2025cites this paper
• Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis

  2025cites this paper
• A proposal of visual assessment of serotonergic deficits in parkinsonian syndromes: An 123I-FP-CIT SPECT study

  2025cites this paper
• A Usability Pilot Study of a Sensor-Guided Interactive System for Dexterity Training in Parkinson’s Disease

  2025cites this paper
• Social cognition in basal ganglia pathologies: Theory of Mind in Huntington’s and Parkinson’s diseases

  2025cites this paper
• Mental State Recognition Deficits Linked to Brain Changes in Parkinson's Disease Without Dementia

  2025cites this paper
• Amygdala Neurodegeneration: A Key Driver of Visual Dysfunction in Parkinson's Disease

  2025cites this paper
• The impact of motor, non-motor, and social aspects on the sexual health of women living with Parkinson's disease

  2025cites this paper
• Early detection of Parkinson’s disease through multiplex blood and urine biomarkers prior to clinical diagnosis

  2025cites this paper
• Differentiating idiopathic Parkinson’s disease from multiple system atrophy-P using brain MRI-based radiomics: a multicenter study

  2025cites this paper
• Rhythmic auditory cues improve gait asymmetry during unobstructed walking in people with Parkinson’s disease but have no effect on obstacle avoidance - AsymmGait-Parkinson study

  2025cites this paper
• Digital Phenotyping of Parkinson’s Disease via Natural Language Processing

  2025cites this paper
• Altered functional activity and connectivity in Parkinson’s disease with chronic pain: a resting-state fMRI study

  2025cites this paper
• Projections for prevalence of Parkinson’s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021

  2025cites this paper
• Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit

  2025cites this paper
• Region-specific variations in the cerebrovasculature underlie disease progression in Parkinson’s disease

  2025cites this paper
• Reconsidering brain MRI in apparently classical Parkinson’s disease: one-time structural imaging for every patient?

  2025influential citation
• Interaction Between Traffic-Related Air Pollution and Parkinson Disease Polygenic Risk Score

  2025cites this paper
• PARylation in Parkinson’s disease: a bridge between Lewy body formation and neuronal cell death

  2025cites this paper
• Can simple behavioural interventions increase daily physical activity in Parkinson’s disease?

  2025cites this paper
• Locus coeruleus neuromelanin, cognitive dysfunction, and brain metabolism in multiple system atrophy

  2025cites this paper